30 November 2026 target set for Titomic redomiciliation scheme

November target resets the redomiciliation clock

Titomic Limited (ASX:TTT) has put a date against its proposed move to the United States, currently targeting implementation of the scheme of arrangement by 30 November 2026. The timetable is indicative rather than fixed, with the company warning that Court processes and the satisfaction or waiver of scheme conditions could still change the schedule.

The proposal would make newly formed Delaware company Titomic, Inc. the group’s US parent. It is a corporate change with a practical distinction for Australian investors: the ASX listing is intended to remain under ticker TTT, but shareholders would receive CHESS Depositary Interests rather than ordinary shares in an Australian parent.

CDI structure preserves ASX trading

Under the proposed arrangement, eligible shareholders would retain an equivalent proportional economic interest in Titomic Group through CDIs, subject to the scheme’s treatment of ineligible foreign holders. The CDIs would represent beneficial interests in shares of the US company and could continue to be bought and sold on the ASX.

The key investor information has not yet arrived. Titomic says the Scheme Booklet will set out the share-to-CDI exchange arrangements, CDI holder rights, Australian tax implications, key risks and the Independent Expert’s Report before shareholders vote. No action is required from shareholders at this stage.

US defence access is the strategic rationale

Titomic says the US domicile is intended to improve its positioning within the American defence and aerospace ecosystem, including access to Tier-1 manufacturers, suppliers, research institutions and skilled workers. It also points to potential eligibility for non-dilutive funding opportunities through the US Small Business Administration and Office of Strategic Capital, as well as closer alignment with “Made in America” requirements and the Department of War’s “Arsenal of Freedom” initiative.

The company has also identified regulatory access as a reason for the restructure. Opportunities involving ITAR controls, the National Industrial Security Program and Facility Security Clearance requirements may require a US corporate structure, according to the announcement. Those are stated strategic objectives, however, rather than evidence that any particular government programme, funding application or security clearance has been secured.

Formal approvals remain the decisive hurdle

The proposed timetable places the shareholder meeting and voting record date in mid-November, followed by a second Court date and the expected effectiveness of the scheme in late November. New Titomic US HoldCo CDIs are expected to begin deferred-settlement trading around that time, with normal T+2 ASX settlement targeted for early December if the transaction proceeds.

Shareholder approval is only one part of the pathway. Court approval and other conditions must also be satisfied or waived, while the proposed US exchange listing remains something Titomic, Inc. intends to pursue “at an appropriate time” rather than a transaction condition or committed near-term event. The next material test is therefore not the timetable itself, but whether the Scheme Booklet gives shareholders enough detail to assess the legal, tax, custody and market-access trade-offs of becoming CDI holders in a US parent.